Arcellx (ACLX) Shares Issued (2021 - 2025)
Arcellx's (ACLX) quarterly Shares Issued came in at $6.8 million in Q4 2025, down 6.45% year-on-year from $7.2 million in Q4 2024, and down 6.45% quarter-over-quarter from $7.2 million in Q4 2024.
Arcellx (ACLX) Shares Issued (2021 - 2025) Analysis & Trends
Arcellx's Shares Issued history runs 5 years deep, the most recent figure standing at $6.8 million for Q4 2025.
- On a quarterly basis, Shares Issued fell 6.45% year-over-year to $6.8 million in Q4 2025; TTM through Dec 2025 was $6.8 million, a 6.45% decrease from a year earlier, with the FY2025 full-year figure at $6.8 million, down 6.45% from the prior year.
- Shares Issued fell to $6.8 million in Q4 2025 per ACLX's latest filing, from $7.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $8.5 million in Q2 2023 and bottomed at $1.8 million in Q1 2022.
- The 5-year median for Shares Issued is $7.8 million (2023), against an average of $6.8 million.
- Across the five-year window, Shares Issued soared 109.72% in 2023 and declined 7.31% in 2024, its largest moves.
- Year by year, Shares Issued stood at $5.6 million in 2021, then soared by 43.85% to $8.1 million in 2022, then declined by 3.01% to $7.8 million in 2023, then slipped by 7.31% to $7.2 million in 2024, then retreated by 6.45% to $6.8 million in 2025.
- Per Business Quant, the three latest ACLX Shares Issued figures stand at $6.8 million (Q4 2025), $7.2 million (Q4 2024), and $7.8 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 6.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.77 Mn |
| Dec 31, 2025 | 6.77 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Dec 31, 2023 | 7.81 Mn |
| Dec 31, 2023 | 7.81 Mn |
| Sep 30, 2023 | 8.15 Mn |
| Sep 30, 2023 | 8.15 Mn |
| Jun 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 8.49 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Sep 30, 2022 | 8.44 Mn |
| Sep 30, 2022 | 8.44 Mn |
| Jun 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.23 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.77 Mn |